- Open Access
Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis
Cell Communication and Signalingvolume 17, Article number: 10 (2019)
Deregulated c-Abl activity has been intensively studied in a variety of solid tumors and leukemia. The class-I carcinogen Helicobacter pylori (Hp) activates the non-receptor tyrosine kinase c-Abl to phosphorylate the oncoprotein cytotoxin-associated gene A (CagA). The role of c-Abl in CagA-dependent pathways is well established; however, the knowledge of CagA-independent c-Abl processes is scarce.
c-Abl phosphorylation and localization were analyzed by immunostaining and immunofluorescence. Interaction partners were identified by tandem-affinity purification. Cell elongation and migration were analyzed in transwell-filter experiments. Apoptosis and cell survival were examined by FACS analyses and MTT assays. In mice experiments and human biopsies, the involvement of c-Abl in Hp pathogenesis was investigated.
Here, we investigated the activity and subcellular localization of c-Abl in vitro and in vivo and unraveled the contribution of c-Abl in CagA-dependent and -independent pathways to gastric Hp pathogenesis. We report a novel mechanism and identified strong c-Abl threonine 735 phosphorylation (pAblT735) mediated by the type-IV secretion system (T4SS) effector D-glycero-β-D-manno-heptose-1,7-bisphosphate (βHBP) and protein kinase C (PKC) as a new c-Abl kinase. pAblT735 interacted with 14–3-3 proteins, which caused cytoplasmic retention of c-Abl, where it potentiated Hp-mediated cell elongation and migration. Further, the nuclear exclusion of pAblT735 attenuated caspase-8 and caspase-9-dependent apoptosis. Importantly, in human patients suffering from Hp-mediated gastritis c-Abl expression and pAblT735 phosphorylation were drastically enhanced as compared to type C gastritis patients or healthy individuals. Pharmacological inhibition using the selective c-Abl kinase inhibitor Gleevec confirmed that c-Abl plays an important role in Hp pathogenesis in a murine in vivo model.
In this study, we identified a novel regulatory mechanism in Hp-infected gastric epithelial cells by which Hp determines the subcellular localization of activated c-Abl to control Hp-mediated EMT-like processes while decreasing cell death.
Helicobacter pylori (Hp) is a human class-I carcinogen that exclusively colonizes the gastric epithelium of approximately 50% of the world’s population. Successful Hp colonization requires sophisticated strategies to survive the hostile gastric environment and to prevent clearance by the immune system. Persistent infections with Hp are considered as the main factor responsible for chronic gastritis, ulceration, lymphoma of the MALT system and gastric cancer [1, 2]. While MALT lymphoma can be treated by antibiotics as the first line therapy, the prognosis of gastric cancer is still poor and represents one of the leading causes for cancer-related deaths worldwide. Surgery is the only curative treatment, since chemo-, radiation-, or targeted therapies are not efficient in advanced stages of gastric cancer and fail to prevent epithelial-mesenchymal transition (EMT)-driven tumor spreading . Gastric cancer can be distinguished in cardia (gastro-esophageal junction) and non-cardia adenocarcinomas caused by altered cell proliferation, survival, apoptosis and (epigenetic) modifications of tumor suppressor genes (cdh1, tp53, kras, etc.) [3, 4]. Hence, Hp-mediated tumorigenesis and gastric cancer progression involve a complex network of signaling cascades which allows persistent colonization and causes the induction of inflammatory and carcinogenic responses.
The genome of highly virulent Hp strains harbors a cag pathogenicity island (cagPAI), which encodes a specialized type-4 secretion system (T4SS). Via the T4SS pilus, Hp translocates the effector protein CagA into the cytoplasm of gastric epithelial cells [5, 6]. CagA is initially tyrosine phosphorylated (pCagA) in its Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs by members of the Src kinase family [7, 8] followed by phosphorylation through c-Abl to maintain pCagA in later phases of Hp infections [9, 10]. In fact, pCagA is considered as an important driver of oncogenic processes. Transgenic mice systemically expressing CagA suffer from gastric epithelial hyperplasia, gastric polyps, hematological malignancies and adenocarcinomas. This report provides a direct and causative link between pCagA and the development of Hp-associated neoplasms .
The pathogenic function of CagA has been demonstrated in vivo in animal models [12, 13] and in cultured gastric epithelial cells in vitro [14,15,16]. Hp-infected AGS cells display a strongly elongated cell morphology resembling the cell scattering phenotype in response to hepatocyte growth factor (HGF) [17, 18]. Hp-mediated cell elongation is strictly dependent on Src- and c-Abl-mediated CagA phosphorylation [9, 10] and is associated with the CagA-independent loss of intercellular adhesion and enhanced cell migration. These processes are implicated in the development of an EMT-like phenotype, which represents a critical step during metastasis .
The non-receptor tyrosine kinase c-Abl exhibits manifold cellular functions and its structure and regulation have been well studied [20, 21]. It contains protein-protein interaction domains, DNA- and actin-binding motifs, nuclear localization signals (NLS) and nuclear export signals (NES). The kinase activity can be activated by numerous pathways including platelet-derived growth factor receptor (PDGFR), epidermal growth factor receptor (EGFR) or through substrate interaction  and is accompanied by phosphorylation at tyrosine 245 (pAblY245) and tyrosine 412 (pAblY412) [21, 23]. The consequences of kinase activation range from cytoskeleton rearrangements, cell motility, and proliferation to DNA damage response and apoptotic pathways [24, 25]. These opposing effects are mainly regulated via the subcellular localization of the kinase. NLS and NES sequences regulate shuttling of c-Abl between the cytoplasm and the nucleus. In the cytoplasm, c-Abl is involved in the regulation of actin dynamics and proliferation. Accordingly, many of the identified kinase substrates (e.g. Crk proteins, cortactin, Wave, etc.) are closely associated with cell morphology and migration [22, 26]. In contrast, nuclear c-Abl contributes to the DNA damage response  and apoptosis [27, 28]. Therefore, a balanced nucleo-cytoplasmic transport of c-Abl is a tightly regulated process in normal cells. c-Abl expression, activity and localization are frequently deregulated in human leukemia, but also in solid tumors, and is implicated in neoplastic transformation and cancer progression [29, 30]. It has been shown that cytoplasmic localization is mainly regulated by interaction with members of the 14–3-3 protein family, which preferentially bind to phosphorylated threonine 735 (pAblT735) and thereby mask the NLS motifs [31, 32]. The drastic consequences of cytoplasmic Abl kinase activity are displayed by the oncogenic breakpoint cluster region (BCR)-Abl fusion protein. A vast majority of chronic myeloid leukemia (CML) cases are caused by the Philadelphia translocation, which results in a constitutively active BCR-Abl representing the paradigm of therapeutic intervention using specific kinase inhibitors [20, 33].
Gastric cancer cells can leave the primary tumor, invade the surrounding extracellular matrix (ECM), and metastasize to distal sites; however, it is not fully understood how these invasive cells survive in a foreign environment. These processes likely involve the inactivation of apoptotic mechanisms and uncontrolled proliferation. In our previous work, we identified c-Abl as a crucial molecule for CagA functions in Hp-infected gastric epithelial cells [9, 10]. Besides its influence on CagA, the cellular consequences of activated c-Abl are largely unknown. Hence, we analyzed how Hp controls c-Abl subcellular localization and influences cell fate in vitro and in vivo.
Cell and bacterial culture
The gastric epithelial cancer cell lines AGS (ECACC, no. 89090402) and MKN-28 (MPI for Infection Biology in Berlin, JCRB, no. 0253) were cultured in RPMI-1640 (Sigma Aldrich, Vienna, Austria) containing 10% FCS (Sigma Aldrich, Austria) and 2 mM L-glutamine (Biowest, France) at 37 °C in a humidified 5% CO2 atmosphere. MCF-7 cells (ATCC, no. HTB-22) were cultured in DMEM medium (Sigma Aldrich, Austria) containing 10% FCS and 2 mM L-glutamine at 37 °C in a humidified 10% CO2 atmosphere. Hp P12 wildtype was cultured on horse serum agar plates for 24 to 48 h at 37 °C under microaerophilic conditions using the CampyGen system (Oxoid, Austria). Hp P12 wt, ΔPAI, ΔCagA, ΔVacA, ΔRfaE, ΔCagL and ΔCagL/CagL isogenic mutant strains have been described previously [34,35,36,37]. Additional Western (P1, Hp26695, and B8) and East Asian isolates (42GX, 48GX) of Hp has been reported elsewhere [38,39,40,41]. Hp was harvested in PBS, pH 7.4 (Sigma Aldrich, Austria) and added to host cells at a multiplicity of infection (MOI) as indicated. Cells were routinely serum starved for one hour before infection. Where indicated, cells were stimulated with 100 nM phorbol-12-myristat-13-acetat (PMA, Sigma Aldrich, Austria), 10 μM H2O2/100 μM sodium vanadate, 10 μM of the 14–3-3 inhibitor BV02 (Sigma-Aldrich, Austria), or pretreated with 10 μM STI-571 (LC Laboratories, MA, USA) to block c-Abl. To inhibit protein kinase A (PKA) activity, 10 μM PKI (Sigma Aldrich, Austria) was used. PKC inhibitors Gö6983 and BIM have been described elsewhere  and were obtained from Sigma Aldrich (Austria).
DNA constructs and transfection
The plasmids pSGT-Ablwt, pSGT-AblKD (K290R) and pSGT-AblPP (P242E, P249E) have been described previously . The constructs pSGT-AblTA, pSGT-AblY245F, pSGT-AblY412F, pNTAP-Ablwt, and pNTAP-AblTA have been generated by site directed mutagenesis (Quikchange Lightning, Agilent Technologies, Germany). All constructs were verified by sequencing.
Transient transfection, siRNA and generation of stable cell lines
Cells were transfected with 5 μg plasmid using polyethylenimine (Polysciences Europe, Germany). For the generation of stable cell lines, AGS cells were transfected with linearized pNTAP-Ablwt and pNTAP-AblTA plasmids and selected using G418 (Sigma-Aldrich, Austria). Generation of stable shAbl knock-down cells and the corresponding negative control (sh control) has been described previously . For siRNA knock-down experiments, siTTK, siPKC (further information in the Additional file 1) and control siRNA oligonucleotides (Santa Cruz Biotechnology, Germany) were co-transfected with pSGT-Ablwt. After 3 days, cells were infected with Hp and analyzed by Western blotting.
SDS PAGE and Western blot
Cells were lysed in 20 mM Tris pH 7.5, 1 mM EDTA, 100 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 x complete protease inhibitor tablets (Roche Diagnostics, Germany), 1 mM sodium molybdate, 20 mM NaF, 10 mM sodium pyrophosphate, 20 mM β-glycerophosphate, 1 mM sodium vanadate. Equal protein amounts were separated by SDS PAGE and transferred onto nitrocellulose. Following antibodies were used: anti-c-Abl (AB3, Merck Biosciences, Germany), anti-pAblT735, anti-pCrkIIY221 (both New England Biolabs, Germany), anti-pAblY245, anti-β-actin (both Sigma Aldrich, Germany), anti-pAblY412, anti-GAPDH (both Abcam, UK), anti-CagA , anti-GST (Biomol Germany), anti-14-3-3 H8, anti-phospho-tyrosine (pY99), anti-TTK, and anti-PKC (all Santa Cruz Biotechnology, Germany). Membranes were imaged using the Molecular Imager ChemiDoc XRS system (BioRad, Germany). Where indicated, signals of protein bands were quantified using the ImageLab software (BioRad, Germany).
Immunoprecipitation, in vitro kinase reaction and TAP pull down experiments
c-Abl was precipitated from 500 μg whole cell lysates using 3 μg anti-c-Abl (AB3, Merck Biosciences, Germany). The in vitro kinase reaction was performed in 20 mM HEPES pH 7.4, 10 mM MgCl2, 10 mM MnCl2, 250 μM ATP using 250 ng purified GST-Crk aa 120–225  for 30 min at 30 °C. PKC-mediated c-Abl phosphorylation was performed using 10 ng/μl recombinant PKCαβγ (Merck Millipore, Germany), 100 ng/μl recombinant c-Abl (Merck Millipore, Germany) and 250 μM ATP for 10 min at 30 °C in an assay dilution buffer II reaction buffer (Merck Millipore, Germany). To activate PKC activity, a PKC lipid activator (Merck Millipore, Germany) has been added to the reaction as recommend by manufacturer’s instructions. TAP pull-downs were performed using the Interplay Mammalian TAP System (Agilent Technologies, Austria) according to the manufacturer’s manual.
Cells were grown on coverslips, transfected with pSGT-Ablwt or pSGT-AblTA and infected for the indicated periods of time. Cells were washed twice with PBS, fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, followed by blocking in 1% bovine serum albumin (BSA). Cells were stained using 0.5 μg/ml anti-c-Abl (AB3, Merck Biosciences, Germany). Cells were counterstained with phalloidin-Alexa-Fluor546 (ThermoFisher Scientific, Austria) and DAPI (Sigma Aldrich, Austria). Imaging was performed using an AxioObserver Z1 (Zeiss, Austria). Cell elongation was determined by measuring the largest cell diameter using ZEN2 (Zeiss) and Fiji software. c-Abl-positive cells were measured in 4–6 random frames per experiment from four independent infection experiments. Nuclear and cytoplasmic localization of c-Abl was quantitated by measuring the integrated intensities of the nuclear and cytoplasmic areas stained by DAPI and phalloidin in 4–6 random frames per experiment from four independent infection experiments. The cytoplasmic c-Abl was calculated as total cell c-Abl intensity (set as 100%) minus nuclear c-Abl intensity.
Quantification of cell migration
AGS cells stably expressing TAP-Ablwt or TAP-AblTA were seeded in 8 μm transwell filter inserts (BD Biosciences, Austria). Next day, the medium was replaced by RPMI supplemented with 1% FCS. After 24 h, cells were infected with Hp at a MOI 50 for 8 h. Non-migrating cells were removed and migrating cells were stained by Giemsa and counted.
Apoptosis and MTT assay
Apoptosis was measured using PE annexin V Apoptosis Detection Kit I (BD Biosciences, Austria). Caspase-8 and caspase-9 activation was determined using the Milliplex human early apoptosis kit (Millipore, Germany). For MTT assays, cells were incubated with 0.5 mg/ml 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Sigma-Aldrich, Austria) for 1 h at 37 °C in the dark. Cells were lysed using isopropylalcohol containing 0.1% NP-40 and 0.04 N HCl. Absorbance was read at 565 nm in a Tecan M200 plate reader.
Mouse colonization experiments
C57BL/6 mice were infected with 107 Hp strain PMSS1 for two months. Mice were either left untreated or were treated with 75 mg/kg per day STI-571 in the drinking water. Colony-forming units (cfu) were determined by plating and colony counting. Paraffin sections were stained with hematoxylin and eosin (H&E) for grading of histopathological changes. Details can be found in the Additional file 1.
Immunohistochemical staining of human gastric biopsies for c-Abl and pAblT735 was performed on routinely FFPE tissue, using a standardized automated platform (AutostainerPlus, Dako, DN) in combination with Envision polymer detection system (Agilent Technologies, Austria). Details can be found in the Additional file 1.
Statistical evaluations for cell culture experiments were calculated using Student’s t-test with GraphPad Prism 5. For the animal experiments statistics was calculated using Wilcoxon-Mann-Whitney test with GraphPad Prism 5. Statistics for the human gastric biopsy specimen was calculated using Bonferroni corrected least significant difference test using SPSS software.
Hp regulates c-Abl tyrosine and threonine phosphorylation via different signaling pathways
Although c-Abl plays a well documented crucial role in Hp pathogenesis, the complex network of kinase regulation has not been investigated in detail. To analyze the regulatory phosphorylation sites, c-Abl was transiently transfected to facilitate the detection of phospho-c-Abl. For the first time, we could show pAblT735 phosphorylation in Hp-infected cells, which was weak in non-infected AGS cells, but strongly induced after 4 and 6 h of Hp infection. Concomitantly, Hp induced the phosphorylation of pAblY245 and pAblY412, but also a slight increase of c-Abl protein amount was observed (Fig. 1a), which has been previously reported and was attributed to miRNA-203 silencing . The amounts of c-Abl and pAblT735 in Hp-infected cells were quantified and correlated with non-infected cells. A drastic increase in pAblT735 phosphorylation was observed, which outbalanced the minor effects of c-Abl accumulation (Additional file 2: Figure S1A), underlining that Hp effectively induced pAblT735 phosphorylation. This could also be detected in MKN28 (Additional file 2: Figure S1B) and MCF-7 cells (Additional file 2: Fig. S1C), which have been established as suitable Hp infection models . MKN28 cells, which express higher levels of endogenous c-Abl , were analyzed by immunoprecipitation to detect endogenous pAblT735 upon Hp infection (Additional file 2: Figure S1D). We further analyzed multiple Western and East Asian Hp isolates and observed a robust pAblT735 phosphorylation (Additional file 2: Figure S1E). In line with the detected tyrosine phosphorylation pattern, c-Abl kinase activity was strongly activated at later time points after Hp infection as reflected by the phosphorylation of the c-Abl substrate GST-Crk in in vitro phosphorylation assays (Fig. 1b). A set of various isogenic Hp deletion mutants was analyzed, which Hp factors are involved in the regulation of c-Abl. CagA is encoded by the cag pathogenicity island (cagPAI) which also harbors the genes important for the structure and function of the T4SS including the T4SS adhesin CagL . The vacuolating toxin VacA has been described as an inducer of vacuolization and apoptosis . In comparison to Hp wildtype (wt), a ∆cagPAI-deficient strain failed to mediate pAblY245 or pAblY412 phosphorylation. This is in contrast to pAblT735, which was only partially affected by the deletion of the cagPAI (Fig. 1c). Therefore, we investigated whether the T4SS adhesin CagL triggers pAblT735 phosphorylation. CagL expression in Hp wildtype and the complemented ∆CagL mutant was necessary for phosphorylation of pAblY245 or pAblY412, but not for pAblT735 (Additional file 3: Figure S2A-B). In addition, CagA deficiency resulted in a slight decrease in c-Abl tyrosine phosphorylation, but exhibited no effect on the pAblT735 phosphorylation. Finally, loss of VacA expression did not influence pAblT735 phosphorylation, but increased pAblY245 or pAblY412 phosphorylation. Detection of CagA and translocated pCagA validated Hp mutants (Fig. 1c). Recently, βHBP was identified as a new T4SS effector [37, 49]. The rfaE-deficient Hp mutant exhibits a defect in the HBP biosynthesis and did not mediate pAblT735 phosphorylation while pAblY245 was still induced (Fig. 1d and Additional file 3: Figure S2C). Additionally, cells were stimulated with PMA or H2O2/vanadate serving as positive controls for phosphorylation of pAblT735, pAblY245 and pAblY412, respectively (Fig. 1c-d). These data suggest that the T4SS-dependent βHBP effector is implicated in the control of c-Abl threonine phosphorylation while tyrosine phosphorylation and activation of c-Abl is CagL/CagA-dependent.
To analyze whether phosphorylation of pAblT735 is linked to pAblY245 or pAblY412, a panel of c-Abl mutants targeting kinase activity and phosphorylation sites was generated for a detailed characterization of their potential mutual regulation. We created phosphorylation-resistant mutants of threonine 735 (AblTA), tyrosine 245 (AblY245F) and tyrosine 412 (AblY412F) and analyzed them together with constitutively active (AblPP) and a kinase-dead version of c-Abl (AblKD) in Western blot and densitometric analyses (Additional file 4: Figure S3A-D). Compared to Ablwt, neither AblY245F nor AblY412F or AblKD significantly affected pAblT735 phosphorylation. As expected, AblTA expression completely abrogated pAblT735 phosphorylation signals (Additional file 4: Figure S3A, right panel and S3B). Corresponding to the AblY245F or AblY412F mutants, treatment of AGS cells with STI-571 efficiently blocked pAblY245 phosphorylation, but did not change pAblT735 phosphorylation (Additional file 4: Figure S3E). The analyses of pAblY245 or pAblY412 phosphorylation verified the functionality of the respective mutants. The lack tyrosine 245 phosphorylation of AblPP is due to the exchange of the prolines 242 and 249 to glutamates, which interferes with pAblY245 phosphorylation (Additional file 4: Figure S3A, left panel). Importantly, pAblY245 and pAblY412 were hyper-phosphorylated in cells transfected with the AblTA construct (Additional file 4: Figure S3A, left panel and S3C-D). Interestingly, pAblY245 was also abrogated in the AblY412F mutant pointing to a hierarchical phosphorylation of these sites. In contrast, pAblY412 was unaffected by the AblY245F mutant (Additional file 4: Figure S3A, left panel and Additional file 4: Figure S3C-D). Further, overexpression of Ablwt induced an increase in CagA phosphorylation, while cells expressing AblTA exhibited an attenuated pCagA signal (Additional file 4: Figure S3A, right panel). Unsurprisingly, constitutive active AblPP strongly increased pCagA, whereas AblKD, AblY245F, and AblY412F clearly reduced pCagA signals (Additional file 4: Fig. S3A, right panel). The data imply that pAblT735 and pAblY245 phosphorylations are induced by different Hp factors and upstream signal transduction pathways.
PKC is a novel kinase for phosphorylation of pAblT735 which causes cytoplasmic retention, increases cell migration and limits apoptosis
In previous studies TTK/Mps1 has been proposed to mediate phosphorylation of pAblT735 . In addition, online kinase prediction tools (NetPhos, http://www.cbs.dtu.dk/services/NetPhos/) yielded PKC as putative pAblT735 kinase. Therefore, we tested the influence of both, TTK and PKC by knock-down of protein expression using specific siRNA. TTK-targeting siRNA resulted in efficient down-regulation of TTK expression; however, Hp-induced pAblT735 was not affected as compared to control siRNA (Fig. 2a). In contrast, PKC knock-down strongly inhibited the phosphorylation of pAblT735 (Fig. 2a). PKC activation has previously been shown to play a crucial role in Hp-mediated cell elongation and scattering . In fact, Hp induced a robust PKC activation (Fig. 2b). To confirm that PKC plays a direct role in the upstream signaling of pAblT735, PKC activity was blocked using Gö6983 and BIM. In contrast to the protein kinase A inhibitor (PKI) used as a negative control, Gö6983 slightly affected phosphorylation of pAblT735, while bis(indolyl)maleimide (BIM) drastically reduced the phosphorylation of pAblT735 (Fig. 2c). Even though the inhibitors Gö6983 and BIM enhanced the basal level of PKC phosphorylation, which has been observed previously , Hp did not further stimulate an increase in pPKC (Fig. 2c). In an in vitro kinase assay, recombinant PKCα/β/γ (rPKC) directly phosphorylated recombinant c-Abl (rAbl), which was again blocked by BIM, but not by the PKCδ-specific inhibitor rottlerin (Fig. 2d). Since PKCγ expression is restricted to neuronal cells , these data point to PKCα/β as Hp-regulated kinases that directly phosphorylate pAblT735 in gastric epithelial cells.
To identify potential interaction partners of c-Abl in Hp-infected cells tandem-affinity purification (TAP) experiments were performed. Differential Hp-dependent binding patterns were observed in TAP-Ablwt- and TAP-AblTA-expressing cells (Fig. 3a). Phosphorylation of TAP-Ablwt and TAP-AblTA was verified by Western blotting (Additional file 5: Figure S4A). Candidate proteins were then analyzed by mass-spectrometry and members of the 14–3-3 family were identified (Table 1). In line with pAblT735 signals, a weak interaction of c-Ablwt with 14–3-3 was observed in non-infected cells and binding was drastically increased upon infection with Hp. This interaction was completely abolished in cells expressing c-AblTA (Fig. 3b).
14–3-3 interaction can cause cytoplasmic retention of c-Abl through binding to the phosphorylated threonine residue 735 and thus masking the NLS sequences. This interaction was shown to hinder the nuclear import of c-Abl in response to genotoxic or oxidative stress [32, 51]. Therefore, we analyzed the subcellular localization of c-Abl in Hp-infected cells. Immunofluorescence microscopy of AGS cells expressing c-Ablwt (Fig. 4a) or c-AblTA (Fig. 4b) was performed. Both, non-infected c-Ablwt and c-AblTA-expressing cells showed no distinct localization and c-Abl was distributed in the cytoplasmic and nuclear compartment. This picture changed after infection with Hp. Here, c-Ablwt showed nuclear exclusion and preferentially localized to perinuclear regions (Fig. 4a). In contrast, c-AblTA was mainly localized in the nuclei of infected cells (Fig. 4b). Quantification of nuclear c-Abl localization verified the retention of Ablwt in the cytoplasm compared to AblTA (Additional file 4: Figure S3F). In Hp infections, the differential localization pattern was also accompanied by a reduced elongation phenotype, which was quantified by evaluating elongation of c-Abl-positive cells. Cells expressing c-Ablwt exhibited the typical elongated cell morphology, which was drastically reduced in c-AblTA-positive cells (Fig. 4c and Additional file 5: Figure S4B). This observation was further confirmed by the finding that c-AblTA expression led to a drastic decrease in Hp-induced cell migration as compared to c-Ablwt expressing cells (Fig. 4d) implying that cytoplasmic localization of c-Abl is involved in actin cytoskeleton reorganization leading to cell elongation and motility. Importantly, the 14–3-3 antagonist BV02 clearly inhibited cell elongation (Additional file 4: Figure S3G), which underlines the significance of 14–3-3 binding in the regulation of cytoplasmic Abl functions in Hp-infected cells.
c-Abl is implicated in the DNA damage response by supporting G1 arrest and DNA repair and it also contributes to programmed cell death via p73- and presumably p63-dependent mechanisms [52, 53]. Hp is known to induce significant levels of apoptosis in vitro  and in vivo . Therefore, we analyzed whether c-Abl contributes to the Hp-mediated apoptotic response. As expected, Hp induced apoptosis in a MOI-dependent manner (Fig. 5a). To analyze the role of c-Abl in cell survival, a c-Abl-deficient AGS cell line using stable shRNA-mediated RNA interference and a control cell line was employed  (Fig. 5b). In line with our hypothesis, c-Abl knock-down (shAbl) resulted in a significantly reduced apoptosis as compared to the control shRNA (shCtr) as monitored by MTT experiments (Fig. 5b) and apoptosis assays (Additional file 5: Figure S4E). Interestingly, this observation was also independent of CagA suggesting that the pro-apoptotic effect is mediated directly via c-Abl (Fig. 5b). Concomitantly with reduced cell death, we could also show decreased caspase-8 (Fig. 5c) and caspase-9 activation (Fig. 5d) in shAbl cells. Efficient knockdown of endogenous c-Abl expression in AGS cells was verified by Western blotting and the decrease in Hp-mediated cell elongation (Additional file 5: Figure S4C-D). Consequently, the observation that mutational disruption of the c-Abl/14–3-3 interaction resulted in increased nuclear localization of the AblTA mutant in Hp infected cells led to the question whether this also causes increased apoptosis. Ectopic TAP-AblTA expression rendered the cells more sensitive to apoptosis than TAP-Ablwt after Hp infection (Fig. 6a), which was accompanied by an increased activation of caspase-8 (Fig. 6b) and caspase-9 (Fig. 6c) downstream of nuclear c-Abl processes . These data support our conclusion that increased nuclear localization of AblTA correlates with increased apoptosis, while cell migration is inhibited.
Increased c-Abl expression and phosphorylation in Hp pathologies in vivo
To investigate whether Hp exhibited similar effects on c-Abl expression and phosphorylation in vivo, we analyzed gastric tissue samples obtained from patients diagnosed with type C (chemically induced) gastritis or Hp-associated B gastritis and compared them to healthy controls. Hp-associated gastritis specimens displayed a considerable tissue infiltrate with lymphocytes. Concomitantly, a strong increase in the expression of c-Abl was observed. Importantly, an increased phosphorylation of pAblT735 was detected in the Hp-positive samples, but not in type C gastritis (Fig. 7a). Histological scoring of c-Abl and pAblT735 resulted in a significant association between Hp infections, enhanced c-Abl expression and phosphorylation of pAblT735 in the gastric epithelium and gastric glands (Fig. 7b).
Next, we addressed the role of c-Abl in Hp-associated pathogenesis using a murine infection model. The kinase activity of c-Abl was pharmacologically inhibited using Gleevec (STI-571), which did not induce gastric pathologies in uninfected mice . C57BL/6 mice were infected with Hp for two months and were analyzed for successful colonization (Fig. 7c, right panel) and disease parameters were quantified by histology (Fig. 7c, left panel and Additional file 6: Figure S5). Despite the long-term treatment with Gleevec, we observed a similar level of colonization and inflammation in both groups. Apart from inflammation all disease parameters were decreased in the Gleevec-treated animals. In particular reduction of hyperplasia was highly significant (p = 0.0091) (Fig. 7c and Additional file 6: Figure S5). This further underlines the critical contribution of the c-Abl signaling axis in the onset and progression of Hp-induced pathology.
The implication of c-Abl in Hp pathogenesis is well established and a multifaceted deregulation of host cell signaling has been demonstrated in Hp-infected cells in vitro and animal models [9, 10, 45]. Importantly, c-Abl is responsible for sustained CagA phosphorylation after inactivation of Src kinases in gastric epithelial cells and significantly contributes to cytoskeletal rearrangement and cell motility resulting in an EMT-like scatter-phenotype [9, 10]. However, little is known about the regulation of c-Abl in this complex network of signaling cascades. Here, we report a novel mechanism of c-Abl regulation in Hp-infected cells and demonstrate that pAblT735 functions as decisive switch for the subcellular localization of c-Abl. This reinforces cytoplasmic processes facilitating cell migration and elongation, while pro-apoptotic effects in the nucleus are prevented (Fig. 8).
The nuclear functions of c-Abl have been intensively investigated and include DNA damage response, inhibition of cell growth and apoptosis . In our experiments, we found that nuclear localization of c-AblTA increases apoptosis and caspase activation. These data are supported by findings that nuclear c-Abl promotes apoptosis in a p73- and p63-dependent manner, and eventually activates the intrinsic apoptosis pathway and initiator caspases in a feedback loop [52, 56, 58]. The cytoplasmic functions of c-Abl are less well defined. Interestingly, in Hp-infected cells, endogenous c-Abl mainly localizes in the cytoplasm and was also detected in focal adhesion contacts  suggesting that deregulated c-Abl promotes cell elongation and migration. A similar subcellular distribution was observed in cells ectopically expressing c-Abl and we identified pAblT735 phosphorylation as a critical regulator of its subcellular localization (Fig. 8). The discovery of Hp-mediated pAblT735 adds an important novel aspect in the c-Abl-mediated regulation of cytoplasmic and nuclear processes in Hp-infected epithelial cells. Mechanistically, we showed that 14–3-3 binds to c-Abl in a phospho-threonine 735-dependent manner and thus forces cytoplasmic localization . Hence, activated c-Abl in the cytoplasm potentiates cytoskeletal rearrangements, which are implicated in cell elongation and migration, while nuclear depletion attenuated apoptosis in response to Hp (Fig. 8).
Recent publications suggested that TTK/Mps1 can directly phosphorylate pAblT735 upon oxidative stress . Instead of TTK, we identified Hp-activated PKCs as novel kinases that directly phosphorylate pAblT735 (Fig. 8). Hp induces a wide range of conventional, novel and atypical PKCs; therefore, PKCs are interesting targets per se in Hp pathogenesis since they are involved in proliferation, cell scattering and cellular invasion [42, 59]. Hence, the identification of c-Abl as a novel PKC substrate might represent a missing link between PKC activation and the aforementioned cellular responses. pAblT735 was induced independently of CagA, but required a functional T4SS. This is in agreement with a study of Sokolova et al. showing that PKC activation is mediated by T4SS-dependent and T4SS-independent factors . This points to the hypothesis that CagL could trigger pAblT735 possibly via β1-integrin activation, since it has been suggested that c-Abl activation and its nuclear export is regulated via integrin signaling . In fact, tyrosine phosphorylation of c-Abl is CagA- and CagL-dependent, and both factors were shown to activate β1-integrin signaling [15, 36]. However, in our experiments CagL was not solely responsible for pAblT735, but we detected a significant influence of the newly identified T4SS effector βHBP. βHBP is delivered independently of CagA into host cells where it activates the ALPK1-TIFAsome-NF-kB pathway [37, 49]. Therefore, we propose a model that βHBP links the T4SS to the anti-apoptotic function of cytoplasmic c-Abl and that different signal transduction pathways are involved to control phospho-tyrosine-dependent c-Abl activity and phospho-threonine-dependent subcellular localization.
Importantly, c-Abl is a disease-promoting factor in Hp-associated gastric pathologies in vivo. First, a significant increase in c-Abl levels was observed in the gastric epithelium and glands in patients suffering from Hp-associated gastritis, but not in type-C gastritis. The elevated expression levels were accompanied by a drastic phosphorylation of pAblT735 and a preferential cytoplasmic localization in analyzed specimens. Second, in murine infection models we demonstrated that continuous inhibition of c-Abl kinase activity alleviated Hp-induced gastric disease parameters, particularly mucus pit cell/epithelial hyperplasia. Together, the in vivo experiments indicate that the observed effects of c-Abl are crucially involved in lasting and chronic Hp infections, which exceed the time frames typically covered in in vitro settings.
In previous studies we have shown that Hp activates c-Abl kinase to maintain CagA phosphorylation [9, 10]. The finding that Hp infections do not only induce c-Abl kinase activity, but also forces cytoplasmic localization of the activated kinase, where it promotes cell migration and elongation and actively prevents apoptosis (Fig. 8) adds an important new aspect to the complex mechanism of Hp-mediated carcinogenesis.
Cytotoxin-associated gene A
- Hp :
Protein kinase C
Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113(3):321–33.
Peek RM Jr, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208(2):233–48.
Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet (London, England). 2016;388(10060):2654–64.
Correa P. Gastric cancer: overview. Gastroenterol Clin N Am. 2013;42(2):211–7.
Backert S, Tegtmeyer N, Selbach M. The versatility of helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter. 2010;15(3):163–76.
Hatakeyama M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15(3):306–16.
Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem. 2002;277(9):6775–8.
Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. C-Src/Lyn kinases activate helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol. 2002;43(4):971–80.
Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, et al. C-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and east Asian helicobacter pylori strains. J Clin Invest. 2012;122(4):1553–66.
Poppe M, Feller SM, Romer G, Wessler S. Phosphorylation of helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene. 2006;26(24):3462–72.
Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, et al. Transgenic expression of helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci. 2008;105(3):1003–8.
Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe. 2007;2(4):250–63.
Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, et al. Regulation of gastric carcinogenesis by helicobacter pylori virulence factors. Cancer Res. 2008;68(2):379–87.
Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of helicobacter pylori CagA protein. Science (New York, NY). 2002;295(5555):683–6.
Jimenez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog. 2009;5(12):e1000684.
Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S. The helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 2003;22(3):515–28.
Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the c-met receptor and enhances the motogenic response. J Cell Biol. 2003;161(2):249–55.
Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001;42(3):631–44.
Wessler S, Backert S. Molecular mechanisms of epithelial-barrier disruption by helicobacter pylori. Trends Microbiol. 2008;16(8):397–405.
Hantschel O, Nagar B, Guettler S, Kretzschmar J, Dorey K, Kuriyan J, et al. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell. 2003;112(6):845–57.
Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell. 2003;112(6):859–71.
Sirvent A, Benistant C, Roche S. Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biol Cell. 2008;100(11):617–31.
Brasher BB, Van Etten RA. C-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J Biol Chem. 2000;275(45):35631–7.
Shaul Y, Ben-Yehoyada M. Role of c-Abl in the DNA damage stress response. Cell Res. 2005;15(1):33–5.
Yoshida K, Miki Y. Enabling death by the Abl tyrosine kinase: mechanisms for nuclear shuttling of c-Abl in response to DNA damage. Cell Cycle. 2005;4(6):777–9.
Feller SM, Knudsen B, Hanafusa H. C-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 1994;13(10):2341–51.
Hopkins S, Linderoth E, Hantschel O, Suarez-Henriques P, Pilia G, Kendrick H, et al. Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis. Dev Cell. 2012;23(3):547–59.
Yoshida K. PKCdelta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal. 2007;19(5):892–901.
Fiore LS, Ganguly SS, Sledziona J, Cibull ML, Wang C, Richards DL, et al. C-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene. 2014;33(36):4508–20.
Gu JJ, Rouse C, Xu X, Wang J, Onaitis MW, Pendergast AM. Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis. JCI insight. 2016;1(21):e89647.
Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol. 2005;7(3):278–85.
Nihira K, Taira N, Miki Y, Yoshida K. TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress. Oncogene. 2008;27(58):7285–95.
Trela E, Glowacki S, Blasiak J. Therapy of chronic myeloid leukemia: twilight of the imatinib era? ISRN oncology. 2014;2014:596483.
Wessler S, Hocker M, Fischer W, Wang TC, Rosewicz S, Haas R, et al. Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J Biol Chem. 2000;275(5):3629–36.
Schmitt W, Haas R. Genetic analysis of the helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol. 1994;12(2):307–19.
Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007;449(7164):862–6.
Zimmermann S, Pfannkuch L, Al-Zeer MA, Bartfeld S, Koch M, Liu J, et al. ALPK1- and TIFA-dependent innate immune response triggered by the helicobacter pylori type IV secretion system. Cell Rep. 2017;20(10):2384–95.
Corthesy-Theulaz I, Porta N, Pringault E, Racine L, Bogdanova A, Kraehenbuhl JP, et al. Adhesion of helicobacter pylori to polarized T84 human intestinal cell monolayers is pH dependent. Infect Immun. 1996;64(9):3827–32.
Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen helicobacter pylori. Nature. 1997;388(6642):539–47.
Farnbacher M, Jahns T, Willrodt D, Daniel R, Haas R, Goesmann A, et al. Sequencing, annotation, and comparative genome analysis of the gerbil-adapted helicobacter pylori strain B8. BMC Genomics. 2010;11:335.
Wang J, Court M, Jeremy AH, Aboshkiwa MA, Robinson PA, Crabtree JE. Infection of Mongolian gerbils with Chinese helicobacter pylori strains. FEMS Immunol Med Microbiol. 2003;36(3):207–13.
Brandt S, Wessler S, Hartig R, Backert S. Helicobacter pylori activates protein kinase C delta to control Raf in MAP kinase signalling: role in AGS epithelial cell scattering and elongation. Cell Motil Cytoskeleton. 2009;66(10):874–92.
Barila D, Superti-Furga G. An intramolecular SH3-domain interaction regulates c-Abl activity. Nat Genet. 1998;18(3):280–2.
Krisch LM, Posselt G, Hammerl P, Wessler S. CagA phosphorylation in helicobacter pylori-infected B cells is mediated by the nonreceptor tyrosine kinases of the Src and Abl families. Infect Immun. 2016;84(9):2671–80.
Craig VJ, Cogliatti SB, Rehrauer H, Wündisch T, Müller A. Epigenetic silencing of MicroRNA-203 dysregulates ABL1 expression and drives helicobacter-associated gastric lymphomagenesis. Cancer Res. 2011;71(10):3616–24.
Weydig C, Starzinski-Powitz A, Carra G, Lower J, Wessler S. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in helicobacter pylori pathogenicity. Exp Cell Res. 2007;313(16):3459–71.
Schneider S, Carra G, Sahin U, Hoy B, Rieder G, Wessler S. Complex cellular responses of helicobacter pylori-colonized gastric adenocarcinoma cells. Infect Immun. 2011;79(6):2362–71.
McClain MS, Beckett AC, Cover TL. Helicobacter pylori Vacuolating toxin and gastric Cancer. Toxins. 2017;9(10).
Stein SC, Faber E, Bats SH, Murillo T, Speidel Y, Coombs N, et al. Helicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis. PLoS Pathog. 2017;13(7):e1006514.
Saito N, Shirai Y. Protein kinase C gamma (PKC gamma): function of neuron specific isotype. J Biochem. 2002;132(5):683–7.
Yoshida K. Nuclear trafficking of pro-apoptotic kinases in response to DNA damage. Trends Mol Med. 2008;14(7):305–13.
Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C, et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med. 2009;15(10):1179–85.
Meltser V, Ben-Yehoyada M, Shaul Y. C-Abl tyrosine kinase in the DNA damage response: cell death and more. Cell Death Differ. 2011;18(1):2–4.
Wagner S, Beil W, Westermann J, Logan RP, Bock CT, Trautwein C, et al. Regulation of gastric epithelial cell growth by helicobacter pylori: Offdence for a major role of apoptosis. Gastroenterology. 1997;113(6):1836–47.
Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by helicobacter pylori. Gut. 1996;38(4):498–501.
Raina D, Pandey P, Ahmad R, Bharti A, Ren J, Kharbanda S, et al. C-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J Biol Chem. 2005;280(12):11147–51.
Van Etten RA. Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol. 1999;9(5):179–86.
Maiani E, Diederich M, Gonfloni S. DNA damage response: the emerging role of c-Abl as a regulatory switch? Biochem Pharmacol. 2011;82(10):1269–76.
Sokolova O, Vieth M, Naumann M. Protein kinase C isozymes regulate matrix metalloproteinase-1 expression and cell invasion in helicobacter pylori infection. Gut. 2013;62(3):358–67.
Lewis JM, Baskaran R, Taagepera S, Schwartz MA, Wang JYJ. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic–nuclear transport. Proc Natl Acad Sci. 1996;93(26):15174–9.
We thank Giulio Superti-Furga for the pSGT-Ablwt/PP/KD constructs and Jean Crabtree for the strains 42Gx and 48Gx. We are grateful to Ariane Benedetti for her excellent technical assistance.
The work of GP was supported by the EMBO Short-Term Fellowship 7427. SW was supported by the grants P_24315 and W_1213 from the Austrian Science Fund (FWF) and by the Deutsche Forschungsgesellschaft (DFG 2843).
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article and its additional files.
Ethics approval and consent to participate
Human gastric biopsies as formalin-fixed paraffin embedded (FFPE) tissue samples were obtained from anonymous diagnostic material (Institute of Pathology, SALK Salzburg). C57BL/6 mice were bred and maintained in the University of Zurich animal facility in accordance with federal and cantonal guidelines. All animal experimentation was reviewed and approved by the Zurich Cantonal Veterinary office (license 63/2008, to A. Müller).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information. (DOCX 32 kb)
Figure S1. c-Abl threonine phosphorylation in AGS, MKN28 and MCF-7 cells. (A) AGS cells were transfected with pSGT-Ablwt and either left untreated or infected with Hp wt for the indicated periods of time. Levels of pAblT735 (white bars) and total Abl (black bars) were quantified by blot densitometry and normalized to GAPDH. Fold changes compared to uninfected cells are shown. (B) MKN28 and (C) MCF-7 cells were transfected with pSGT-Abl and either left untreated or infected with Hp for the indicated periods of time. Levels of pAblT735, total c-Abl and GAPDH are shown. (D) Lysates of uninfected (−) and Hp-infected (+) MKN28 cells were subjected to immunoprecipitation (IP) using a specific c-Abl antibody. Lysates before IP (pre IP), the precipitates (IP) and lysates after IP (post IP) were analyzed by Western blotting to detect pAblT735 and c-Abl. (E) Transfected AGS cells were infected with several Western (P12, P1, Hp26695 and B8) and East Asian Hp isolates (42GX and 48GX) and analyzed by Western blotting to detect pAblT735, c-Abl and GAPDH. (DOCX 180 kb)
Figure S2. Tyrosine phosphorylation, but not threonine phosphorylation of c-Abl depends on CagL. (A) AGS cells were transfected with pSGT-Ablwt and remained uninfected or were infected with isogenic Hp wt, ΔCagL, or ΔCagL/CagL strains for 6 h. Whole cell lysates were subjected to Western blotting to analyze pAblT735, pAblY245 and pAblY412. c-Abl and β-actin were shown as loading controls. Infections were further analyzed for pCagA and CagA. (B) Quantification of pAblT735, pAblY245 and pAblY412 was performed by Western blot densitometry, which was normalized to corresponding β-actin levels. Graphs show mean ± SD of three independent experiments. (C) Cells were infected with Hp wt, ΔRfaE or ΔPAI. pAblT735, AblY245, pCagA, CagA and GAPDH were detected using specific antibodies. (DOCX 2290 kb)
Figure S3. Differential phosphorylation patterns in c-Abl mutants. (A) AGS cell were transfected with pSGT-Ablwt, pSGT-AblTA, pSGT-AblPP, pSGT-AblKD, pSGT-AblY245F, pSGT-cAblY412F, or empty vector (ut) and either left untreated, infected with Hp wt or stimulated with H2O2/vanadate (H/V, left panel) or PMA (right panel) for 6 h. Whole cell lysates were analyzed by Western blotting for pAblT735, pAblY245 or pAblY412, pCagA, CagA, GAPDH and β-actin. Quantification of pAblT735 (B) pAblY245 (C) and pAblY412 (D) were performed by blot densitometry and normalized to the corresponding β-actin levels. Graphs present mean ± SD of three independent experiments. (E) Transfected AGS cells were pretreated with 10 μM STI-571 and infected with Hp for 6 h as indicated. Whole cell lysates were analyzed by Western blotting for pAblT735, pAblY245, Abl and GAPDH. (F) AGS cells were transfected with pSGT-Ablwt or pSGT-AblTA and then infected with Hp for 4 h. Nuclear and cytoplasmic localization was quantified from four independent experiments. (G) AGS stably transfected with pNTAP Ablwt were pretreated with a 14–3-3 inhibitor (BV02) or vehicle control (DMSO) and infected with Hp for 8 h. Cell elongation was determined by measuring the largest cell diameter of individual cells from three independent experiments. (DOCX 310 kb)
Figure S4. Generation of stable AGS cell lines. (A) Untreated AGS cells and AGS cells transfected with TAP-Ablwt or TAP-AblTA were either left untreated (mock) or infected with Hp at a MOI 100 for 6 h and analyzed by Western blot for pAblT735 and c-Abl. β-actin served as loading control. (B) Untreated AGS cells and AGS cells expressing TAP-Ablwt or TAP-AblTA were either left untreated (mock) or infected with Hp at a MOI 100. The scattering phenotype was documented using phase contrast microscopy. (C) Untreated AGS cells and AGS cells stably transfected with control shRNA (shCtrl) or c-Abl shRNA (shAbl) were lysed and analyzed by Western blotting for c-Abl and GAPDH expression (D) AGS cells stably transfected with control shRNA (shCtrl) or c-Abl shRNA (shAbl) were either left untreated (mock) or infected with Hp at a MOI 100 for 6 h. Scattering phenotype was documented using phase contrast microscopy. (E) AGS cells stably transfected with control (shCtr) or Abl shRNA (shAbl) were left untreated (−) or infected with Hp wt for 48 h. Percent apoptosis was calculated by analyzing annexin single-positive and annexin/7AAD positive cells. (DOCX 276 kb)
Figure S5. Gleevec decreases Hp pathology. C57BL/6 mice were infected with Hp PMSS1 for two months, were supplied with STI-571 or remained untreated (control). Representative sections of the gastric tissues are shown. (DOCX 261 kb)